Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

PHACE syndrome

Dawn H Siegel, MD
Section Editor
Moise L Levy, MD
Deputy Editor
Rosamaria Corona, MD, DSc


PHACE syndrome (posterior fossa anomalies, hemangioma, arterial anomalies, cardiac anomalies, and eye anomalies) is an uncommon disorder of unknown etiology characterized by large segmental hemangiomas of the face and various developmental defects. The term "PHACE(S)" is sometimes used in the presence of ventral developmental defects, which include sternal cleft, supraumbilical raphe, or both. Since the original description in 1996 [1], significant advances have been made in refining the diagnostic criteria, imaging guidelines, and knowledge of associated morbidities and complications [2]. Previous terms for this condition have included Pascual-Castroviejo syndrome [3] and sternal malformation-vascular dysplasia association [4].

This topic will review the pathogenesis, clinical features, diagnosis, and management of PHACE syndrome. Infantile hemangiomas are discussed separately:

(See "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications".)

(See "Infantile hemangiomas: Evaluation and diagnosis".)

(See "Infantile hemangiomas: Management".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Jun 19, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996; 132:307.
  2. Garzon MC, Epstein LG, Heyer GL, et al. PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations. J Pediatr 2016; 178:24.
  3. Pascual-Castroviejo I, López-Gutiérrez JC, Pascual-Pascual SI, et al. [Cutaneous hemangiomas, vascular malformations and associated disorders. A new neurocutaneous syndrome]. An Pediatr (Barc) 2003; 58:339.
  4. Hersh JH, Waterfill D, Rutledge J, et al. Sternal malformation/vascular dysplasia association. Am J Med Genet 1985; 21:177.
  5. www.chw.org/medical-care/birthmarks-and-vascular-anomalies-center/conditions/phace-syndrome/phace-syndrome-registry/ (Accessed on November 08, 2016).
  6. Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010; 126:e418.
  7. Bayer ML, Frommelt PC, Blei F, et al. Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the International PHACE Syndrome Registry). Am J Cardiol 2013; 112:1948.
  8. Etchevers HC, Vincent C, Le Douarin NM, Couly GF. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 2001; 128:1059.
  9. Padget DH. The development of the cranial arteries in the human embryo. Contrib Embryol 1948; 32:205.
  10. Metry DW, Siegel DH, Cordisco MR, et al. A comparison of disease severity among affected male versus female patients with PHACE syndrome. J Am Acad Dermatol 2008; 58:81.
  11. Sullivan CT, Christian SL, Shieh JT, et al. X Chromosome-Inactivation Patterns in 31 Individuals with PHACE Syndrome. Mol Syndromol 2013; 4:114.
  12. Siegel DH, Shieh JT, Kwon EK, et al. Copy number variation analysis in 98 individuals with PHACE syndrome. J Invest Dermatol 2013; 133:677.
  13. Haggstrom AN, Lammer EJ, Schneider RA, et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006; 117:698.
  14. Nabatian AS, Milgraum SS, Hess CP, et al. PHACE without face? Infantile hemangiomas of the upper body region with minimal or absent facial hemangiomas and associated structural malformations. Pediatr Dermatol 2011; 28:235.
  15. Antonov NK, Spence-Shishido A, Marathe KS, et al. Orbital Hemangioma with Intracranial Vascular Anomalies and Hemangiomas: A New Presentation of PHACE Syndrome? Pediatr Dermatol 2015; 32:e267.
  16. Metry D, Heyer G, Hess C, et al. Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics 2009; 124:1447.
  17. Thomson J, Greig A, Lloyd C, et al. PHACE syndrome misdiagnosed as a port-wine stain. BMJ Case Rep 2015; 2015.
  18. Durr ML, Meyer AK, Huoh KC, et al. Airway hemangiomas in PHACE syndrome. Laryngoscope 2012; 122:2323.
  19. Duffy KJ, Runge-Samuelson C, Bayer ML, et al. Association of hearing loss with PHACE syndrome. Arch Dermatol 2010; 146:1391.
  20. Hess CP, Fullerton HJ, Metry DW, et al. Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 2010; 31:1980.
  21. Erturk O, Uygunoglu U, Celkan T, Yalcinkaya C. Prenatal unilateral cerebellar hypoplasia diagnosed as PHACE syndrome. Childs Nerv Syst 2016; 32:587.
  22. Denzer F, Denzer C, Lennerz BS, et al. A case of phace syndrome and acquired hypopituitarism? Int J Pediatr Endocrinol 2012; 2012:20.
  23. Brandon K, Burrows P, Hess C, Metry D. Arteriovenous malformation: a rare manifestation of PHACE syndrome. Pediatr Dermatol 2011; 28:180.
  24. Patel U, Gupta SC. Wyburn-Mason syndrome. A case report and review of the literature. Neuroradiology 1990; 31:544.
  25. Wang H, Oh AK, Orbach DB. Arteriovenous shunting as a new feature of PHACES. Case report. J Neurosurg Pediatr 2009; 3:53.
  26. Siegel DH, Tefft KA, Kelly T, et al. Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE) syndrome: a systematic review of the literature. Stroke 2012; 43:1672.
  27. Heyer GL, Dowling MM, Licht DJ, et al. The cerebral vasculopathy of PHACES syndrome. Stroke 2008; 39:308.
  28. Sathishkumar D, George R, Irodi A, Thomas M. PHACES syndrome with moyamoya vasculopathy - a case report. Dermatol Online J 2013; 19:19271.
  29. Burrows PE, Robertson RL, Mulliken JB, et al. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 1998; 207:601.
  30. Jack AS, Chow MM, Fiorillo L, et al. Bilateral pial synangiosis in a child with PHACE syndrome. J Neurosurg Pediatr 2016; 17:70.
  31. Lopez-Gutierrez JC. PHACES syndrome and ectopia cordis. Interact Cardiovasc Thorac Surg 2011; 12:642.
  32. Oza VS, Wang E, Berenstein A, et al. PHACES association: a neuroradiologic review of 17 patients. AJNR Am J Neuroradiol 2008; 29:807.
  33. Metry DW, Haggstrom AN, Drolet BA, et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 2006; 140:975.
  34. Puvanachandra N, Heran MK, Lyons CJ. Morning glory disk anomaly with ipsilateral capillary hemangioma, agenesis of the internal carotid artery, and Horner syndrome: a variant of PHACES syndrome? J AAPOS 2008; 12:528.
  35. Metry DW, Dowd CF, Barkovich AJ, Frieden IJ. The many faces of PHACE syndrome. J Pediatr 2001; 139:117.
  36. Brosig CL, Siegel DH, Haggstrom AN, et al. Neurodevelopmental Outcomes in Children with PHACE Syndrome. Pediatr Dermatol 2016; 33:415.
  37. Martin KL, Arvedson JC, Bayer ML, et al. Risk of dysphagia and speech and language delay in PHACE syndrome. Pediatr Dermatol 2015; 32:64.
  38. Poindexter G, Metry DW, Barkovich AJ, Frieden IJ. PHACE syndrome with intracerebral hemangiomas, heterotopia, and endocrine dysfunction. Pediatr Neurol 2007; 36:402.
  39. Carinci S, Tumini S, Consilvio NP, et al. A case of congenital hypothyroidism in PHACE syndrome. J Pediatr Endocrinol Metab 2012; 25:603.
  40. Mamlouk MD, Yu JP, Asch S, Mathes EF. PHACE syndrome and congenitally absent thyroid gland at MR imaging. Clin Imaging 2016; 40:237.
  41. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000; 343:185.
  42. Altin H, Alp H, Sap F, et al. PHACE syndrome with growth hormone deficiency and absence of bilateral internal carotid arteries: a case report. Pediatr Dermatol 2012; 29:316.
  43. Uihlein LC, Garzon MC, Goodwin G, Liang MG. Growth hormone replacement in patients with PHACE association and hypopituitarism. Pediatr Dermatol 2014; 31:337.
  44. Goddard DS, Liang MG, Chamlin SL, et al. Hypopituitarism in PHACES Association. Pediatr Dermatol 2006; 23:476.
  45. Merheb M, Hourani R, Zantout MS, Azar ST. Endocrine dysfunction in a patient with PHACE syndrome, including port-wine stain of the right periorbital area. Endocr Pract 2010; 16:255.
  46. Yu J, Siegel DH, Drolet BA, et al. Prevalence and Clinical Characteristics of Headaches in PHACE Syndrome. J Child Neurol 2016; 31:468.
  47. Chiu YE, Siegel DH, Drolet BA, Hodgson BD. Tooth enamel hypoplasia in PHACE syndrome. Pediatr Dermatol 2014; 31:455.
  48. Iacobas I, Burrows PE, Frieden IJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr 2010; 157:795.
  49. Kronenberg A, Blei F, Ceisler E, et al. Ocular and systemic manifestations of PHACES (Posterior fossa malformations, Hemangiomas, Arterial anomalies, Cardiac defects and coarctation of the Aorta, Eye abnormalities, and Sternal abnormalities or ventral developmental defects) syndrome. J AAPOS 2005; 9:169.
  50. Spence-Shishido AA, Good WV, Baselga E, Frieden IJ. Hemangiomas and the eye. Clin Dermatol 2015; 33:170.
  51. Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 2013; 131:128.
  52. Metry D, Frieden IJ, Hess C, et al. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol 2013; 30:71.
  53. Frommelt P, Juern A, Siegel D, et al. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma. Pediatr Dermatol 2016; 33:405.
  54. Püttgen K, Lucky A, Adams D, et al. Topical Timolol Maleate Treatment of Infantile Hemangiomas. Pediatrics 2016; 138.
  55. Weibel L, Barysch MJ, Scheer HS, et al. Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption. Pediatr Dermatol 2016; 33:184.
  56. Caragher SP, Scott JP, Siegel DH, et al. Aortic arch repair in children with PHACE syndrome. J Thorac Cardiovasc Surg 2016; 152:709.
  57. Chou PS, Guo YC. Limb-shaking transient ischemic attacks in an adult PHACE syndrome: a case report and review of the literature. Neurol Sci 2012; 33:305.
  58. Burch EA, Garzon MC, Parikh A, Meyers PM. A 65-year-old woman diagnosed with PHACE syndrome. Pediatr Dermatol 2013; 30:e153.
  59. Arora SS, Plato BM, Sattenberg RJ, et al. Adult presentation of PHACES syndrome. Interv Neuroradiol 2011; 17:137.
  60. Prochazka V, Hrbac T, Chmelova J, et al. PHACE Syndrome: Persistent Fetal Vascular Anomalies. A Case Report. Interv Neuroradiol 2005; 11:355.